BAUPOST GROUP LLC/MA Diversified Active

Location: Boston, MA

CIK: 0001061768 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 25, 2017

Total Value: $8.493B (99.3% shares, 0.7% debt)

Holdings (43)

LNG CHENIERE ENERGY INC 12.1%
Value $1.027B Shares 21,726,340 Est. Cost $57.55 Unrealized -19.9%
VSAT VIASAT INC 9.9%
Value $840M Shares 13,158,137 Est. Cost $61.22 Unrealized +7.1%
TWENTY FIRST CENTY FOX INC 7.3%
Value $620M Shares 19,137,469 Est. Cost $26.78 Unrealized
COLONY NORTHSTAR INC 7.3%
Value $618M Shares 47,905,461 Est. Cost $12.91 Unrealized
SYF SYNCHRONY FINL 7.1%
Value $606M Shares 17,665,000 Est. Cost $22.53 Unrealized +28.5%
ALLERGAN PLC 6.8%
Value $581M Shares 2,432,603 Est. Cost $240.83 Unrealized
QRVO QORVO INC 5.8%
Value $493M Shares 7,185,514 Est. Cost $64.25 Unrealized 0.0%
DELL TECHNOLOGIES INC 4.3%
Value $362M Shares 5,652,459 Est. Cost $47.80 Unrealized
PBF PBF ENERGY INC 4.1%
Value $349M Shares 15,724,175 Est. Cost $25.25 Unrealized -7.2%
TBPH THERAVANCE BIOPHARMA INC 4.0%
Value $341M Shares 9,273,991 Est. Cost $26.99 Unrealized +18.4%
AR ANTERO RES CORP 3.9%
Value $331M Shares 14,505,881 Est. Cost $34.16 Unrealized -28.3%
QCOM QUALCOMM INC 3.5%
Value $299M Shares 5,216,000 Est. Cost $45.51 Unrealized 0.0%
TWENTY FIRST CENTY FOX INC 2.7%
Value $231M Shares 7,278,100 Est. Cost $27.19 Unrealized
INVA INNOVIVA INC 1.9%
Value $160M Shares 11,573,663 Est. Cost $10.97 Unrealized +7.3%
KERYX BIOPHARMACEUTICALS INC 1.9%
Value $159M Shares 25,791,678 Est. Cost $14.16 Unrealized
VERITIV CORP 1.9%
Value $158M Shares 3,044,385 Est. Cost $46.74 Unrealized
MCK MCKESSON CORP 1.7%
Value $148M Shares 1,000,000 Est. Cost $136.84 Unrealized -0.2%
FORWARD PHARMA A/S 1.4%
Value $120M Shares 5,575,407 Est. Cost $20.86 Unrealized
ATARA BIOTHERAPEUTICS INC 1.3%
Value $110M Shares 5,359,632 Est. Cost $31.66 Unrealized
CAH CARDINAL HEALTH INC 1.0%
Value $84M Shares 1,030,000 Est. Cost $55.30 Unrealized +9.6%
EXPRESS SCRIPTS HLDG CO 1.0%
Value $80.98M Shares 1,228,619 Est. Cost $65.91 Unrealized
SILVER RUN ACQUISITION 0.8%
Value $69M Shares 6,615,554 Est. Cost $10.43 Unrealized
LIBERTY INTERACTIVE CORP 0.8%
Value $65.91M Shares 1,481,719 Est. Cost $36.87 Unrealized
CHIPMOS TECHNOLOGIES INC 0.7%
Value $62.3M Shares 3,509,858 Est. Cost $14.11 Unrealized
CACC CREDIT ACCEP CORP MICH 0.6%
Value $48.74M Shares 244,400 Est. Cost $189.52 Unrealized +6.3%
LIBERTY MEDIA CORP DELAWARE 0.6%
Value $47.16M Shares 1,994,010 Est. Cost $14.66 Unrealized
SYNGENTA AG 0.6%
Value $46.73M Shares 527,968 Est. Cost $79.05 Unrealized
NG NOVAGOLD RES INC 0.5%
Value $46.27M Shares 9,500,000 Est. Cost $2.49 Unrealized +112.1%
GTY TECHNOLOGY HOLDINGS INC 0.5%
Value $45.41M Shares 4,400,000 Est. Cost $10.50 Unrealized
COR AMERISOURCEBERGEN CORP 0.5%
Value $44.47M Shares 502,474 Est. Cost $58.75 Unrealized +13.1%
CENTENNIAL RESOURCE DEV INC 0.5%
Value $41.66M Shares 2,407,153 Est. Cost $18.10 Unrealized
PARATEK PHARMACEUTICALS INC 0.5%
Value $39.36M Shares 2,044,498 Est. Cost $30.44 Unrealized
CONYERS PK ACQUISITION 0.5%
Value $39.35M Shares 3,712,500 Est. Cost $10.00 Unrealized
THERAVANCE BIOPHARMA INC 0.4%
Value $37.76M Shares 30,000,000 Est. Cost $1.14 Unrealized
CASCADIAN THERAPEUTICS INC 0.4%
Value $36.1M Shares 8,721,079 Est. Cost $4.22 Unrealized
AMERICAN INTL GROUP INC 0.3%
Value $26.91M Shares 1,259,012 Est. Cost $19.71 Unrealized
SABAN CAP ACQUISITION CORP 0.3%
Value $23.24M Shares 2,326,500 Est. Cost $10.00 Unrealized
THERAVANCE INC 0.3%
Value $21.4M Shares 22,480,000 Est. Cost $0.86 Unrealized
RUN SUNRUN INC 0.2%
Value $15.38M Shares 2,848,082 Est. Cost $9.81 Unrealized -43.3%
OREXIGEN THERAPEUTICS INC 0.1%
Value $7.66M Shares 2,226,839 Est. Cost $3.32 Unrealized
TMQ TRILOGY METALS INC NEW 0.1%
Value $5.797M Shares 10,600,758 Est. Cost $0.57 Unrealized -12.9%
CONYERS PK ACQUISITION 0.0%
Value $2.537M Shares 1,237,500 Est. Cost $1.15 Unrealized
SABAN CAP ACQUISITION CORP 0.0%
Value $1.57M Shares 1,163,250 Est. Cost $0.95 Unrealized